Clinical Trial

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

Recruiting
View on ClinicalTrials.gov →
Summary
Background: Mitochondrial disease is a rare disorder. It can cause poor growth, developmental delays, muscle weakness, and other symptoms. The disease is usually inherited. It can be present at birth or develop later in life. Infection is a major cause of disease and death in people with this disease. Researchers want to learn more about these infections and the declining health of people who have this disease. To do this, researchers will study the DNA of people who become ill. Their DNA will be compared to the DNA of their household/family members. Objective: To learn more about how genes affect people with mitochondrial disease. Eligibility: People age 2 months and older with mitochondrial disease and their household/family members. .\<TAB\> Design: Participants will complete a questionnaire about their health history. Their medical records may be reviewed. They will give a blood sample. If the participant becomes ill, they may have a videoconference with a doctor or nurse at the NIH to perform a physical exam. They may be contacted after their illness to give updates on their health. They may be asked to give extra blood samples or complete extra questionnaires. Participants genetic data will be put into a database. The data will be labeled with a code and not their name. The data will be shared with other researchers. Participation lasts about 1 year. This may be extended if the participant is very ill.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-01 -> 2027-05-01 2026-05-16
minor Completion pushed: 2026-05-01 -> 2027-05-01 2026-05-16
Trial Details
NCT Number NCT04419870
Lead Sponsor National Human Genome Research Institute (NHGRI)
Conditions Mitochondrial Disease
Enrollment 400 participants
Start Date 2020-10-21
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-22